Cargando…

A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’

Detalles Bibliográficos
Autores principales: Aksan, Aysegül, Schoepfer, Alain, Juillerat, Pascal, Vavricka, Stephan, Bettencourt, Miguel, Ramirez de Arellano, Antonio, Gavata, Simona, Morin, Neige, Valentine, William J., Hunt, Barnaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799560/
https://www.ncbi.nlm.nih.gov/pubmed/34846708
http://dx.doi.org/10.1007/s12325-021-02001-4
_version_ 1784642088108818432
author Aksan, Aysegül
Schoepfer, Alain
Juillerat, Pascal
Vavricka, Stephan
Bettencourt, Miguel
Ramirez de Arellano, Antonio
Gavata, Simona
Morin, Neige
Valentine, William J.
Hunt, Barnaby
author_facet Aksan, Aysegül
Schoepfer, Alain
Juillerat, Pascal
Vavricka, Stephan
Bettencourt, Miguel
Ramirez de Arellano, Antonio
Gavata, Simona
Morin, Neige
Valentine, William J.
Hunt, Barnaby
author_sort Aksan, Aysegül
collection PubMed
description
format Online
Article
Text
id pubmed-8799560
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-87995602022-02-02 A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’ Aksan, Aysegül Schoepfer, Alain Juillerat, Pascal Vavricka, Stephan Bettencourt, Miguel Ramirez de Arellano, Antonio Gavata, Simona Morin, Neige Valentine, William J. Hunt, Barnaby Adv Ther Letter Springer Healthcare 2021-11-30 2022 /pmc/articles/PMC8799560/ /pubmed/34846708 http://dx.doi.org/10.1007/s12325-021-02001-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Aksan, Aysegül
Schoepfer, Alain
Juillerat, Pascal
Vavricka, Stephan
Bettencourt, Miguel
Ramirez de Arellano, Antonio
Gavata, Simona
Morin, Neige
Valentine, William J.
Hunt, Barnaby
A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
title A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
title_full A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
title_fullStr A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
title_full_unstemmed A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
title_short A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
title_sort response to: letter to the editor regarding ‘iron formulations for the treatment of iron deficiency anemia in patients with inflammatory bowel disease: a cost-effectiveness analysis in switzerland’
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799560/
https://www.ncbi.nlm.nih.gov/pubmed/34846708
http://dx.doi.org/10.1007/s12325-021-02001-4
work_keys_str_mv AT aksanaysegul aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT schoepferalain aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT juilleratpascal aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT vavrickastephan aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT bettencourtmiguel aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT ramirezdearellanoantonio aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT gavatasimona aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT morinneige aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT valentinewilliamj aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT huntbarnaby aresponsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT aksanaysegul responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT schoepferalain responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT juilleratpascal responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT vavrickastephan responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT bettencourtmiguel responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT ramirezdearellanoantonio responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT gavatasimona responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT morinneige responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT valentinewilliamj responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland
AT huntbarnaby responsetolettertotheeditorregardingironformulationsforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseaseacosteffectivenessanalysisinswitzerland